Nuvation Bio (NUVB) Accumulated Expenses (2020 - 2026)

At the end of FY2025, Nuvation Bio's Accumulated Expenses came in at $45.18 million, up 37.6% from FY2024.

• Annual Accumulated Expenses shows a five-year compound annual growth rate of 59.5% (FY2020 to FY2025).
• In prior years, Nuvation Bio's Accumulated Expenses was $32.83 million in FY2024 (+235.3%), $9.79 million in FY2023 (-0.2%), $9.82 million in FY2022 (-19.1%) and $12.14 million in FY2021 (+177.1%).
• The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q2 2020.
• On a year-over-year basis, Accumulated Expenses has increased in each of the last ten quarters, with growth averaging 83.4% over the last eight quarters.
• The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2024, with growth of 235.3%; the weakest was Q4 2022, with a decline of 19.1%.
• According to Business Quant data, Accumulated Expenses for the three prior quarters was $32.86 million (Q1 2026), $45.18 million (Q4 2025) and $32.58 million (Q3 2025).